Vivus hopes weight-loss app will fatten up Qsymia sales

Weight-loss apps have become popular, so why not a weight-loss app for a weight-loss drug? Qsymia maker Vivus figures it is worth a try. The company ($VVUS), which has found the uptake slow on its highly vaunted drug, last week launched a mobile version of the weight-loss support tools already on its website, Medical Marketing & Media reports. The app, which works on Android and Apple products, has a diary, so users can note everything they eat and get informational emails rolled out periodically to give them ideas on how to lose weight over a year's time. Report